Huang, Y., Sun, H., Yu, H., Li, S., Zheng, Q., & Xia, N. (2020). Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective. Antibody Therapeutics, 3(4), 285-299.
https://doi.org/10.1093/abt/tbaa028

Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective 

- Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective 

State University of New York at Stony Brook

- Antibody Therapeutics
-  MedRxiv Preprint Papers
- Preprints
- Science

References for Antibodies and COVID-19 by journal

Preprints Papers of Articles Related to Antibodies and COVID-19

-  Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
- SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
-  Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan–[negative] implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2
- Comparative performance of five commercially available serologic assays to detect antibodies to SARS-coV-2 and identify individuals with high neutralizing titers. 

MedRxiv Preprint Papers Related to SARS-CoV-2 Antibody Testing

Antibody Therapeutics Papers Related to Antibodies and COVID-19

- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- Structural basis of a shared antibody response
to SARS-CoV-2

Learn Before

Related

Learn After